As of 2024-12-13, the Relative Valuation of Novartis AG (NOVN.SW) is 109.93 CHF. This relative valuation is based on P/E multiples. With the latest stock price at 88.06 CHF, the upside of Novartis AG based on Relative Valuation is 24.8%.
The range of the Relative Valuation is 76.18 - 163.18 CHF.
| Range | Selected | |
| Trailing P/E multiples | 14.7x - 20.6x | 17.2x |
| Forward P/E multiples | 21.0x - 23.9x | 23.2x |
| Fair Price | 76.18 - 163.18 | 109.93 |
| Upside | -13.5% - 85.3% | 24.8% |
| Date | P/E |
| 2024-12-12 | 11.14 |
| 2024-12-11 | 11.12 |
| 2024-12-10 | 11.23 |
| 2024-12-09 | 11.31 |
| 2024-12-06 | 11.36 |
| 2024-12-05 | 11.43 |
| 2024-12-04 | 11.40 |
| 2024-12-03 | 11.77 |
| 2024-12-02 | 11.78 |
| 2024-11-29 | 11.80 |
| 2024-11-28 | 11.81 |
| 2024-11-27 | 11.73 |
| 2024-11-26 | 11.63 |
| 2024-11-25 | 11.63 |
| 2024-11-22 | 11.85 |
| 2024-11-21 | 11.58 |
| 2024-11-20 | 11.51 |
| 2024-11-19 | 11.52 |
| 2024-11-18 | 11.54 |
| 2024-11-15 | 11.60 |
| 2024-11-14 | 11.73 |
| 2024-11-13 | 11.63 |
| 2024-11-12 | 11.68 |
| 2024-11-11 | 11.77 |
| 2024-11-08 | 11.75 |
| 2024-11-07 | 11.76 |
| 2024-11-06 | 11.86 |
| 2024-11-05 | 11.89 |
| 2024-11-04 | 12.09 |
| 2024-11-01 | 12.08 |
| 2024-10-31 | 11.86 |
| 2024-10-30 | 12.06 |
| 2024-10-29 | 12.11 |
| 2024-10-28 | 12.62 |
| 2024-10-25 | 12.48 |
| 2024-10-24 | 12.43 |
| 2024-10-23 | 12.48 |
| 2024-10-22 | 12.50 |
| 2024-10-21 | 12.70 |
| 2024-10-18 | 12.77 |
| 2024-10-17 | 12.77 |
| 2024-10-16 | 12.75 |
| 2024-10-15 | 12.72 |
| 2024-10-14 | 12.69 |
| 2024-10-11 | 12.58 |
| 2024-10-10 | 12.48 |
| 2024-10-09 | 12.56 |
| 2024-10-08 | 12.34 |
| 2024-10-07 | 12.36 |
| 2024-10-04 | 12.36 |